Press Releases

ViOptix Announces FDA Clearance of Intra.Ox System for Assessment of Tissue Oxygen Saturation (StO2)

Newark, CA, August 2021, ViOptix Inc. announces its Intra.Ox System receives FDA clearance.

The Intra.Ox™ Handheld Tissue Oximeter is intended to non-invasively estimate the percent oxygen saturation (StO2) in a volume of tissue.

In 2013, ViOptix received the prestigious Frost & Sullivan Best Practices Award recognizing superior leadership, technological innovation, customer service, and strategic product development. The company is headquartered in Newark, California.


MORE press releases

how can we help you?

Use this form to send your questions or feedback. We will get back to as soon as possible.

    I am Interested in

    FREE Clinical evaluationCustomer supportJob opportunitiesInvestor information

    * Required fields